Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 823

1.

Emotional Well-Being Is Impaired in Hidradenitis Suppurativa Patients.

Senthilnathan A, Kolli SS, Cardwell LA, Richardson IM, Feldman SR, Pichardo RO.

Skin Appendage Disord. 2019 Nov;5(6):366-369. doi: 10.1159/000502296. Epub 2019 Sep 10.

PMID:
31799265
2.

Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status.

Feldman SR, Zhang J, Martinez DJ, Lopez-Gonzalez L, Marchlewicz EH, Shrady G, Mendelsohn AM, Zhao Y.

J Dermatolog Treat. 2019 Dec 8:1-9. doi: 10.1080/09546634.2019.1698699. [Epub ahead of print]

PMID:
31769703
3.

Contact dermatitis: one for the books.

Su JJ, Haidari W, Hoffman MB, Feldman SR.

Dermatol Online J. 2019 Sep 15;25(9). pii: 13030/qt09f3b9p2.

PMID:
31738850
4.

Unilateral contact dermatitis of the chest.

Ramani LT, Feldman SR.

Dermatol Online J. 2019 Oct 15;25(10). pii: 13030/qt6h61107j.

5.

The rise in subscription skin care services.

Visconti MJ, Haidari W, Feldman SR, Taylor SL.

Dermatol Online J. 2019 Oct 15;25(10). pii: 13030/qt4th6026d.

6.

Treatment Adherence and Persistence of Five Commonly Prescribed Medications for Moderate to Severe Psoriasis in a U.S. Commercially Insured Population.

Wu B, Muser E, Teeple A, Pericone CD, Feldman SR.

J Dermatolog Treat. 2019 Nov 12:1-26. doi: 10.1080/09546634.2019.1687828. [Epub ahead of print]

PMID:
31714168
7.

Assessing perceived side effects of biologic medications for patients with psoriasis.

Bray JK, Cline A, Feldman SR.

J Am Acad Dermatol. 2019 Nov 7. pii: S0190-9622(19)32999-8. doi: 10.1016/j.jaad.2019.11.002. [Epub ahead of print] No abstract available.

PMID:
31706939
8.

Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis.

Frantz T, Wright EG, Balogh EA, Cline A, Adler-Neal AL, Feldman SR.

Children (Basel). 2019 Nov 5;6(11). pii: E125. doi: 10.3390/children6110125.

9.

Differences in healthcare barriers based on racial and/or ethnic background for patients with psoriasis.

Bray JK, Cline A, McMichael AJ, Feldman SR.

J Dermatolog Treat. 2019 Nov 25:1-5. doi: 10.1080/09546634.2019.1687824. [Epub ahead of print]

PMID:
31689125
10.

Comparing psoriasis advertisement methods with patient willingness to initiate treatment.

Bray JK, Cline A, Masicampo EJ, Kammrath L, Feldman SR.

J Dermatolog Treat. 2019 Nov 12:1-5. doi: 10.1080/09546634.2019.1688235. [Epub ahead of print]

PMID:
31682466
11.

Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis.

Li W, Ghamrawi R, Haidari W, Feldman SR.

Ann Pharmacother. 2019 Oct 31:1060028019885836. doi: 10.1177/1060028019885836. [Epub ahead of print]

PMID:
31672037
12.

Complementary and Integrative Therapies for Childhood Atopic Dermatitis.

Adler-Neal AL, Cline A, Frantz T, Strowd L, Feldman SR, Taylor S.

Children (Basel). 2019 Oct 30;6(11). pii: E121. doi: 10.3390/children6110121. Review.

13.

Dermatology nurses view on factors related to Danish psoriasis patients' adherence to topical drugs: a focus group study.

Svendsen MT, Feldman SR, Tiedemann SN, Stochholm Sørensen AS, Rivas CMR, Andersen KE.

J Dermatolog Treat. 2019 Nov 7:1-6. doi: 10.1080/09546634.2019.1687817. [Epub ahead of print]

PMID:
31664863
14.

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.

Langley RGB, Reich K, Strand V, Feldman SR, Paul C, Gordon K, Warren RB, Toth D, Nikaï E, Zhu B, Goldblum O, Edson-Heredia E, Carlier H, Burge R, Lin CY, Hollister K, Augustin M.

Qual Life Res. 2019 Oct 26. doi: 10.1007/s11136-019-02296-5. [Epub ahead of print]

PMID:
31655974
15.

Publication productivity of authors of psoriasis clinical practice guidelines with and without ties to industry.

Kolli SS, Huang WW, Feldman SR.

J Am Acad Dermatol. 2019 Dec;81(6):1432-1433. doi: 10.1016/j.jaad.2019.06.001. Epub 2019 Jun 11. No abstract available.

PMID:
31611054
16.

Psoriasis patient preferences for topical drugs: a systematic review.

Svendsen MT, Feldman SR, Tiedemann SN, Sørensen ASS, Rivas CMR, Andersen KE.

J Dermatolog Treat. 2019 Oct 15:1-6. doi: 10.1080/09546634.2019.1675855. [Epub ahead of print]

PMID:
31610687
17.

How do drug shortages affect dermatologists?

Haidari W, Kolli SS, Feldman SR.

Cutis. 2019 Aug;104(2):90-91. No abstract available.

PMID:
31603957
18.

Accountability in patient adherence.

Oussedik E, Cline A, Su JJ, Masicampo EJ, Kammrath LK, Ip E, Feldman SR.

Patient Prefer Adherence. 2019 Sep 4;13:1511-1517. doi: 10.2147/PPA.S213113. eCollection 2019.

19.

A review of topical corticosteroid sprays for the treatment of inflammatory dermatoses.

Habet KA, Kolli SS, Pona A, Feldman SR.

Dermatol Online J. 2019 Aug 15;25(8). pii: 13030/qt0855j2zz.

20.

An Increasing Trend in the Number of Publications and Research Projects Amongst Dermatology Residency Applicants.

Ezekor M, Pona A, Cline A, Huang WW, Feldman SR.

J Am Acad Dermatol. 2019 Sep 18. pii: S0190-9622(19)32758-6. doi: 10.1016/j.jaad.2019.09.021. [Epub ahead of print] No abstract available.

PMID:
31541752

Supplemental Content

Loading ...
Support Center